 Kathleen Waugh
Concepts (148)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Islets of Langerhans | 12 | 2026 | 833 | 1.470 |
Why?
| | Diabetes Mellitus, Type 1 | 25 | 2026 | 3890 | 1.350 |
Why?
| | Autoantibodies | 20 | 2026 | 1504 | 1.240 |
Why?
| | Autoimmunity | 14 | 2026 | 927 | 0.950 |
Why?
| | Celiac Disease | 6 | 2022 | 308 | 0.740 |
Why?
| | Transglutaminases | 4 | 2021 | 159 | 0.340 |
Why?
| | Luminescent Measurements | 3 | 2021 | 76 | 0.330 |
Why?
| | Mass Screening | 6 | 2021 | 1348 | 0.310 |
Why?
| | Insulin Antibodies | 3 | 2026 | 103 | 0.300 |
Why?
| | Glutens | 2 | 2019 | 59 | 0.290 |
Why?
| | Insulin | 3 | 2026 | 2507 | 0.290 |
Why?
| | Child | 26 | 2026 | 22657 | 0.290 |
Why?
| | Epitopes | 3 | 2025 | 485 | 0.270 |
Why?
| | Child, Preschool | 15 | 2026 | 11799 | 0.230 |
Why?
| | Inflammation | 1 | 2017 | 2880 | 0.230 |
Why?
| | Infant | 13 | 2026 | 10039 | 0.220 |
Why?
| | Blood Proteins | 2 | 2017 | 249 | 0.220 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 8 | 1 | 2025 | 54 | 0.220 |
Why?
| | Disease Progression | 9 | 2026 | 2852 | 0.210 |
Why?
| | CD4-Positive T-Lymphocytes | 3 | 2025 | 1129 | 0.200 |
Why?
| | Electrochemical Techniques | 2 | 2021 | 55 | 0.200 |
Why?
| | Peptide Library | 1 | 2024 | 95 | 0.200 |
Why?
| | GTP-Binding Proteins | 2 | 2021 | 153 | 0.190 |
Why?
| | Vitamin D | 1 | 2026 | 400 | 0.190 |
Why?
| | Bacteriophages | 1 | 2024 | 111 | 0.180 |
Why?
| | Autoantigens | 2 | 2025 | 429 | 0.180 |
Why?
| | Zinc Transporter 8 | 1 | 2021 | 70 | 0.170 |
Why?
| | Insulins | 1 | 2022 | 38 | 0.170 |
Why?
| | Adolescent | 16 | 2026 | 22453 | 0.170 |
Why?
| | Oxylipins | 1 | 2020 | 47 | 0.160 |
Why?
| | Virus Diseases | 1 | 2021 | 216 | 0.150 |
Why?
| | T-Lymphocytes | 2 | 2025 | 1982 | 0.150 |
Why?
| | Male | 23 | 2026 | 72406 | 0.150 |
Why?
| | Humans | 33 | 2026 | 144957 | 0.150 |
Why?
| | Peptides | 2 | 2024 | 998 | 0.140 |
Why?
| | Dietary Proteins | 1 | 2019 | 136 | 0.140 |
Why?
| | Female | 22 | 2026 | 78376 | 0.140 |
Why?
| | Genotype | 2 | 2020 | 1835 | 0.140 |
Why?
| | Genetic Predisposition to Disease | 3 | 2022 | 2365 | 0.130 |
Why?
| | High-Throughput Screening Assays | 1 | 2019 | 175 | 0.130 |
Why?
| | Interferon-gamma | 1 | 2021 | 784 | 0.130 |
Why?
| | Sensitivity and Specificity | 4 | 2026 | 1990 | 0.120 |
Why?
| | Health Care Costs | 1 | 2020 | 427 | 0.120 |
Why?
| | Influenza, Human | 1 | 2022 | 617 | 0.120 |
Why?
| | Eating | 1 | 2019 | 392 | 0.120 |
Why?
| | Autoimmune Diseases | 1 | 2019 | 463 | 0.110 |
Why?
| | DNA Methylation | 1 | 2020 | 683 | 0.110 |
Why?
| | Pediatrics | 2 | 2020 | 1115 | 0.100 |
Why?
| | Prospective Studies | 6 | 2023 | 7997 | 0.100 |
Why?
| | Follow-Up Studies | 5 | 2021 | 5417 | 0.100 |
Why?
| | Biomarkers | 3 | 2021 | 4275 | 0.100 |
Why?
| | Case-Control Studies | 2 | 2020 | 3608 | 0.100 |
Why?
| | Proteome | 1 | 2016 | 518 | 0.090 |
Why?
| | Diet | 1 | 2019 | 1275 | 0.090 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2016 | 906 | 0.090 |
Why?
| | Young Adult | 6 | 2026 | 14126 | 0.090 |
Why?
| | Cytokines | 2 | 2017 | 2065 | 0.090 |
Why?
| | Toll-Like Receptors | 1 | 2012 | 194 | 0.080 |
Why?
| | Oxidative Stress | 1 | 2017 | 1339 | 0.080 |
Why?
| | Gene Expression Profiling | 1 | 2017 | 1786 | 0.080 |
Why?
| | Interleukin-1beta | 1 | 2012 | 395 | 0.080 |
Why?
| | Risk Factors | 5 | 2023 | 10792 | 0.070 |
Why?
| | Adult | 8 | 2026 | 40506 | 0.070 |
Why?
| | Interleukin-6 | 1 | 2012 | 780 | 0.070 |
Why?
| | Prognosis | 3 | 2021 | 4293 | 0.060 |
Why?
| | Proportional Hazards Models | 2 | 2019 | 1325 | 0.060 |
Why?
| | C-Peptide | 1 | 2025 | 189 | 0.050 |
Why?
| | Epitope Mapping | 1 | 2024 | 61 | 0.050 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2026 | 851 | 0.050 |
Why?
| | Cohort Studies | 2 | 2026 | 5965 | 0.050 |
Why?
| | Glycomics | 1 | 2022 | 7 | 0.050 |
Why?
| | Polysaccharides | 1 | 2022 | 87 | 0.050 |
Why?
| | Protein Processing, Post-Translational | 1 | 2025 | 477 | 0.050 |
Why?
| | Longitudinal Studies | 2 | 2020 | 2947 | 0.040 |
Why?
| | Electrochemistry | 1 | 2021 | 74 | 0.040 |
Why?
| | Antibodies | 1 | 2024 | 403 | 0.040 |
Why?
| | Lipoprotein Lipase | 1 | 2002 | 56 | 0.040 |
Why?
| | Sciatic Nerve | 1 | 2002 | 60 | 0.040 |
Why?
| | Ascorbic Acid | 1 | 2023 | 180 | 0.040 |
Why?
| | Diagnostic Techniques, Radioisotope | 1 | 2021 | 9 | 0.040 |
Why?
| | Immunoglobulin D | 1 | 2021 | 29 | 0.040 |
Why?
| | Antigens, Viral | 1 | 2021 | 182 | 0.040 |
Why?
| | China | 1 | 2021 | 269 | 0.040 |
Why?
| | Serologic Tests | 1 | 2021 | 53 | 0.040 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 2022 | 331 | 0.040 |
Why?
| | Asymptomatic Diseases | 1 | 2021 | 102 | 0.040 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2020 | 48 | 0.040 |
Why?
| | Proteomics | 2 | 2017 | 1195 | 0.040 |
Why?
| | Amino Acid Sequence | 1 | 2024 | 2157 | 0.040 |
Why?
| | Quality-Adjusted Life Years | 1 | 2020 | 121 | 0.040 |
Why?
| | Myelin Sheath | 1 | 2002 | 168 | 0.040 |
Why?
| | Immunoglobulin M | 1 | 2021 | 284 | 0.040 |
Why?
| | Whole Genome Sequencing | 1 | 2020 | 183 | 0.040 |
Why?
| | Immunoglobulin A | 1 | 2021 | 214 | 0.040 |
Why?
| | Costs and Cost Analysis | 1 | 2020 | 220 | 0.040 |
Why?
| | Immunoglobulin E | 1 | 2021 | 315 | 0.040 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2020 | 142 | 0.040 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2022 | 550 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2020 | 348 | 0.040 |
Why?
| | Early Diagnosis | 1 | 2020 | 249 | 0.040 |
Why?
| | Diet Surveys | 1 | 2019 | 91 | 0.040 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2022 | 668 | 0.040 |
Why?
| | Cross-Sectional Studies | 2 | 2022 | 5872 | 0.030 |
Why?
| | Middle Aged | 4 | 2025 | 35928 | 0.030 |
Why?
| | Antibodies, Viral | 1 | 2021 | 672 | 0.030 |
Why?
| | Population Surveillance | 1 | 2020 | 485 | 0.030 |
Why?
| | Diabetic Ketoacidosis | 1 | 2020 | 210 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2020 | 636 | 0.030 |
Why?
| | Calcium | 1 | 2023 | 1184 | 0.030 |
Why?
| | Radioimmunoassay | 1 | 2016 | 165 | 0.030 |
Why?
| | Glucose Tolerance Test | 1 | 2018 | 361 | 0.030 |
Why?
| | Disease Management | 1 | 2020 | 647 | 0.030 |
Why?
| | Immunoglobulin G | 1 | 2021 | 893 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2022 | 846 | 0.030 |
Why?
| | Insulin-Secreting Cells | 1 | 2021 | 388 | 0.030 |
Why?
| | Glutamate Decarboxylase | 1 | 2016 | 165 | 0.030 |
Why?
| | C-Reactive Protein | 1 | 2018 | 417 | 0.030 |
Why?
| | HLA-DR Antigens | 1 | 2016 | 220 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2020 | 685 | 0.030 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2020 | 676 | 0.030 |
Why?
| | Incidence | 1 | 2021 | 2883 | 0.030 |
Why?
| | Macrophages | 1 | 2002 | 1511 | 0.030 |
Why?
| | Biopsy | 1 | 2016 | 1077 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2016 | 1540 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2018 | 2118 | 0.020 |
Why?
| | Body Mass Index | 1 | 2020 | 2438 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2019 | 3415 | 0.020 |
Why?
| | Risk Assessment | 1 | 2020 | 3676 | 0.020 |
Why?
| | Feasibility Studies | 1 | 2015 | 1095 | 0.020 |
Why?
| | Hypoglycemic Agents | 1 | 2020 | 1389 | 0.020 |
Why?
| | Transcriptome | 1 | 2016 | 1046 | 0.020 |
Why?
| | Colorado | 1 | 2020 | 4564 | 0.020 |
Why?
| | Exercise | 1 | 2022 | 2201 | 0.020 |
Why?
| | Leukocytes, Mononuclear | 1 | 2012 | 573 | 0.020 |
Why?
| | Age Factors | 1 | 2016 | 3335 | 0.020 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2584 | 0.020 |
Why?
| | Time Factors | 1 | 2017 | 7183 | 0.020 |
Why?
| | Mice | 1 | 2022 | 18365 | 0.010 |
Why?
| | United States | 1 | 2021 | 15988 | 0.010 |
Why?
| | Animals | 2 | 2022 | 38109 | 0.010 |
Why?
| | Nerve Crush | 1 | 2002 | 8 | 0.010 |
Why?
| | Peripheral Nerves | 1 | 2002 | 72 | 0.010 |
Why?
| | Aged | 1 | 2021 | 25947 | 0.010 |
Why?
| | Signal Transduction | 1 | 2012 | 5233 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2002 | 1718 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2002 | 2540 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2002 | 2832 | 0.010 |
Why?
| | Rats | 1 | 2002 | 5614 | 0.010 |
Why?
|
|
Waugh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|